[344] Quantity Versus Quality: Predicting Malignancy in Salivary Gland Neoplasms.
Meenakshi Bhasin, Gretchen E Galliano. David Geffen School of Medicine at UCLA, Los Angeles, CA
Background: Interpretation of salivary gland neoplasms has limitations because of overlapping morphologic features of benign and malignant lesions and a paucity of helpful ancillary tests. This study was conducted to determine if identifying specific morphologic features could improve diagnosis.
Design: Retrospective review was conducted of all salivary gland FNA from 01/01/05 to 06/01/09. Cases with at least one feature were flagged as “high risk” (HRFNA) regardless of diagnosis. Features were: increased cellularity, basaloid morphology, papillary fragments/morphology, irregular nuclear membranes, increased N/C ratio, mucin, prominent nucleoli, hyperchromasia, and coarse chromatin. Cases with myxoid stroma were excluded in the HRFNA evaluation.
Results: Out of 417 cases, 140 met criteria for HRFNA. For all cases (AC), 60% of false positives were due to over interpretation of a paucicellular specimen, and 64% of false negatives were from non-diagnostic or poorly sampled lesions. Characteristics for AC and HRFNA are in table 1. Outcomes of the HRFNA with respect to morphology are in table 2. 60% of HRFNA with benign outcome had 1 "high risk" feature. 78.8% of cases with benign follow up (FU) had <4 high risk features. However, 46% of the cases with malignant FU had<4 features as well.
| ALL CASES | HRFNA | |
|---|---|---|
| SENS | 81.2% | 97.6% |
| SPEC | 89.3% | 66.7% |
| PPV | 96% | 95.3% |
| NPV | 60% | 80% |
| CONCORDANCE | 79.6% | 90.6% |
| Feature (N) | Malignant on SP | Benign on SP |
|---|---|---|
| Coarse chromatin (11) | 11(100%) | 0(0%) |
| Pleomorphism(45) | 41(91%) | 4(9%) |
| Hyperchromasia (11) | 10(90%) | 1(10%) |
| Irregular nuclear membranes (43) | 37 (86%) | 6(14%) |
| High N/C (29) | 24(83%) | 5(17%) |
| Prominent nucleoli (56) | 46(82%) | 10(18%) |
| Cellularity (62) | 43 (69%) | 19(31%) |
| Mucin(8) | 5(62.5%) | 3(37.5%) |
| Basaloid morphology | 3(25%) | 9(75%) |
| Papillary morphology/groups (6) | (0)0% | 6(100%) |